Zhi-Wen Liu
Guangzhou University of Chinese Medicine
Internal medicineEndocrinologyLipogenesisWhite adipose tissueAdipokineEstradiol valerateFatty liverApolipoprotein BMedicineACACAOvariectomized rat
2Publications
0Citations
Publications 3
Newest
#1Peng-Cheng Zhong (Guangzhou University of Chinese Medicine)
#2Rong Shu (Guangzhou University of Chinese Medicine)
Last. Ying-Jie Hu (Guangzhou University of Chinese Medicine)H-Index: 6
view all 6 authors...
Source
#1Zhi-Wen Liu (Guangzhou University of Chinese Medicine)
#2Zhuo-Hui Luo (Guangzhou University of Chinese Medicine)H-Index: 2
Last. Xiao-Ling Shen (Guangzhou University of Chinese Medicine)H-Index: 7
view all 6 authors...
Abstract Background Osteoporosis is a systemic skeletal disease that leads to a high risk for bone fractures. Morinda officinalis How. has been used as osteoporosis treatment in China. However, its mechanism of action as an anti-osteoporotic herb remains unknown. Methods A network pharmacology approach was applied to explore the potential mechanisms of action of M. officinalis in osteoporosis treatment. The active compounds of M. officinalis and their potential osteoporosis-related targets were ...
Source
#1Zhuo-Hui Luo (Guangzhou University of Chinese Medicine)H-Index: 2
#2Zhi-Wen Liu (Guangzhou University of Chinese Medicine)
Last. Xiao-Ling Shen (Guangzhou University of Chinese Medicine)H-Index: 7
view all 8 authors...
ABSTRACT BACKGROUND : Visceral obesity and fatty liver are prevalent in postmenopausal women. The stilbene-rich extract of Cajanus cajan (L.) Millsp. has been reported to prevent ovariectomy-induced and diet-induced weight gain in animal models, and stilbenoids from C. cajan are thought to have the potential to prevent postmenopausal obesity and fatty liver. PURPOSE : Cajanolactone A (CLA) is the main stilbenoid from C. cajan with osteoblastogenic promoting activity. This study investigated the ...
Source
1
Close Researchers